Pain Management After Adductor Canal Block for Total Knee Arthroplasty
CompletedPhase 4NCT06086483
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels.
Study details
- Official title
- Pain Management and Functional Recovery After Adductor Canal Block Combined With iPACK Block for Total Knee Arthroplasty. A Prospective, Randomized, Double-blinded Clinical Trial.
- Conditions
- Knee Osteoarthritis
- Knee Arthritis
- Knee Arthropathy
- Knee Pain Chronic
- Interventions
- Drug: Ropivacaine 0.2% Injectable Solution
- Drug: 0.9%sodium chloride
- Sponsor
- Poznan University of Medical Sciences
- Start date
- 2020-06-18
- Primary completion
- 2022-07-20
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients \> 18 years old undergoing unilateral total knee arthroplasty Exclusion Criteria: * refusal to participate * \< 18 yo * Chronic opioid use * localized infection
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06086483